Professor Redmond specializes in the surgical management of patients with lung cancer, end-stage lung disease, and a range of other prevalent conditions such as pneumothorax, pleural effusion, airway obstruction and chest wall abnormalities.
Professor Redmond was awarded an honours degree with the Gold Medal in Surgery from University College Dublin in 1997. Following a Young Investigators Award for research in lung cancer from the European Association for Cardio-thoracic Surgery, she went on to win the prestigious Society Medal from the Society for Cardiothoracic Surgery in Great Britain and Ireland for her MD work on the “Role of Human Stem Cells in Tumor Angiogenesis”. After completing her specialist training in cardio-thoracic surgery in June 2007, Professor Redmond was awarded a United States Surgical Minimally Invasive Lung Cancer Surgery Scholarship and trained in her subspecialty field of thoracic surgery and lung transplantation at Toronto General Hospital, Canada. There she had the opportunity to consolidate her surgical expertise in keyhole surgery for lung cancer and mesothelioma. Professor Redmond has formally trained on the da Vinci Xi robot to facilitate minimally invasive surgery. She is a member of the UK and European (entros) robotic thoracic surgery interest groups.
The first female lung transplant surgeon to be appointed both in the UK and Ireland, Professor Redmond returned from her consultant post at The Royal Brompton and Harefield NHS Foundation Trust and Imperial College in London in 2011. A record thirty three lung transplants were performed in 2013 with the first pulmonary hypertensive patient receiving a lung transplant. Also, the first lobar lung transplant was performed in a cystic fibrosis recipient and the first non-heart beating donor was implanted into a patient with pulmonary fibrosis. Professor Redmond has international expertise in ex-vivo lung perfusion, a process that allows lungs to be reconditioned (perfused and ventilated) outside the body prior to implantation. These pioneering techniques have helped to increase the number of lung transplants and allow all Irish patients to be treated in the Republic, with repatriation of services from Newcastle
Professor Redmond is frequently invited to chair and/or speak at national and international meetings, and is a reviewer for journals focussed on her subspecialty field of transplantation. She is a member of the Board of Representatives for the Society of Cardiothoracic Surgeons for the UK and ROI, (SCTS) The Cardiothoracic Advisory Group in the UK on matters of transplantation (CTAG), The National Cancer Control Programme Lung Cancer Guidelines Working Group (NCCP), and The Irish Cancer Oncology Research Group (ICORG). Professor Redmond also examines on the JCI intercollegial Consultant fellowship boards.
Working in the Canadian and NHS healthcare systems has been very rewarding, where there is a strong emphasis on governance, quality control and evidence-based commissioning of services. As a consultant in the UK, she was delighted to be offered the opportunity to return to work in Ireland and support the thoracic surgery and lung transplant service in Dublin.